Compared with analyses with county-level PSA screening, associations of county-level mammography screening in years prior to diagnosis were of similar magnitude and statistically significantly associated with lower advanced disease stage at diagnosis compared with county-level PSA screening, but they were less strongly associated with all-cause and prostate cancer–specific mortality (eTable 2 in Supplement 1). The gene discussed is KLK3; the disease is prostate carcinoma.